Research Radboud technology centers Radboud Biobank News Biobanking with invasive procedures
17 October 2019

Recently, the CMO-light decided to allow invasive procedures for biobanking under strict conditions.

When establishing a biobank there is initially no concrete research proposal.  Until recently the METC (CMO-light) did not allow invasive procedures subject to the Medical Research Involving Humans Act for biobanking unless there was a specific research question.  Recently, the CMO-light decided to allow invasive procedures for biobanking under strict conditions. Procedures must be relevant and carry minimal burden and risk for the participants.

For more information please go to the CMO website


 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud Biobank

Related news items


Sub-biobank MEMORY

15 September 2020

The MEMORY biobank focuses on research into biomarkers for memory impairment and dementia and their validation in clinical cohorts.

read more

RYR1 sub-biobank

15 September 2020

The RYR1 biobank is part of a study of the neuromuscular and multisystem features of patients with malignant hyperthermia or rhabdomyolysis related to RYR1 (ryanodine receptor type 1) variants.

read more

New colleague

15 September 2020

My name is Robbert Croes and I started mid 2020 as a data-scientist at the Radboud Biobank.

read more

ProBCI sub-biobank

15 September 2020

There is a pressing need for predictive biomarkers to personalize bladder cancer treatment.

read more

Financial regulation for sub-biobanks

15 September 2020

Sub-biobanks are not required to pay up-front for the processing and storage of biomaterials. The effectiveness of this pre-financing agreement however is dependent on adherence to the demands regarding delivery and processing according to the Radboud Biobank standard operating procedures.

read more